Lixte Biotechnology to Discuss its Collaboration with Leading European Cancer Centers at the ...
Studies to use genome wide functional genetic techniques to identify effective drug combinationsandnew drug targetsfor its lead clinical compound, LB-100 |!| Oelwein
